MarketsStocksPPLPHARMA
PP

Piramal Pharma Ltd

NSE: PPLPHARMABSE: 543635Healthcare
Download Research Report7-page PDF
165.75
-0.61%
NSE · auto-updates while market open
Prev Close
₹206.33
Day High
₹167.98
Day Low
₹164.01
Mkt Cap
₹21,975 Cr
P / E
-
P / B
2.7
ROE
-4.0%
52W High
₹220.85
52W Low
₹132.30
Key Metrics
Market Cap
₹21,975 Cr
P / E
-
P / B
2.69
EV / EBITDA
36.40
ROCE
0.8%
ROE
-4.0%
Debt / Equity
0.67
Book Value
₹61.50
EPS
-
Div Yield
0.1%
Face Value
₹10
Promoter Holding
34.9%
Revenue · ₹ Cr
7.1k
FY23
8.2k
FY24
9.2k
FY25
8.9k
FY26
Net Profit · ₹ Cr
18
91
-186
-326
FY23FY24FY25FY26
EPS · ₹ per share
₹0.1
₹0.7
₹-1.6
FY23FY24FY25
P / E Ratio · price ÷ TTM EPS
17347377310731-10-3Mar 23Apr 24May 25Jun 26
P/E 259.0×Median 667.9×TTM EPS
Q1 2026 snapshot
Sales
₹2.80K Cr
Operating profit
-
OPM
-
Net profit
₹-9 Cr
EPS
₹-0.07
Scorecard · 7 axes
Quality
Weak
36/100
Valuation
-
Growth
Weak
+3.9%
Profitability
Bad
-1.6%
Performance
Bad
-19.9%
Entry Point
Good
75%
Red Flags
Strong
0 flags
Shareholding Pattern
34.9%Promoter
Promoter34.9%
FII30.2%
DII15.6%
Public19.4%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue2,204.222,796.11,992.112,109.322,183.112,797.83
Net Profit3.68153.5-81.7-99.22-136.19-8.82
NPM %0.2%5.5%-4.1%-4.7%-6.2%-0.3%
AlertPre-trade